Takeda Pharmaceutical Co Ltd ADR (TAK) — Cash Flow-to-Debt Ratio
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of $360.04 Billion could theoretically repay 0% of its total liabilities ($7.77 Trillion) in one year. See financial flexibility index of Takeda Pharmaceutical Co Ltd ADR to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Takeda Pharmaceutical Co Ltd ADR Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Takeda Pharmaceutical Co Ltd ADR across 25 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Takeda Pharmaceutical Co Ltd ADR.
Annual Cash Flow-to-Debt Ratio for Takeda Pharmaceutical Co Ltd ADR (2001–2025)
Year-by-year debt coverage analysis for Takeda Pharmaceutical Co Ltd ADR. Check cash flow quality index of Takeda Pharmaceutical Co Ltd ADR to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | $1.06 Trillion | $7.31 Trillion | ▲ +58.1% |
| 2024 | 0.09x | $716.34 Billion | $7.83 Trillion | ▼ -28.9% |
| 2023 | 0.13x | $977.16 Billion | $7.60 Trillion | ▼ -14.2% |
| 2022 | 0.15x | $1.12 Trillion | $7.49 Trillion | ▲ +14.7% |
| 2021 | 0.13x | $1.01 Trillion | $7.74 Trillion | ▲ +57.9% |
| 2020 | 0.08x | $669.75 Billion | $8.09 Trillion | ▲ +119.4% |
| 2019 | 0.04x | $328.48 Billion | $8.71 Trillion | ▼ -79.1% |
| 2018 | 0.18x | $377.85 Billion | $2.09 Trillion | ▲ +66.6% |
| 2017 | 0.11x | $261.36 Billion | $2.41 Trillion | ▲ +672.3% |
| 2016 | 0.01x | $25.49 Billion | $1.81 Trillion | ▼ -83.9% |
| 2015 | 0.09x | $182.52 Billion | $2.09 Trillion | ▲ +19.4% |
| 2014 | 0.07x | $148.34 Billion | $2.03 Trillion | ▼ -58.8% |
| 2013 | 0.18x | $307.71 Billion | $1.73 Trillion | ▼ -20.6% |
| 2012 | 0.22x | $336.57 Billion | $1.51 Trillion | ▼ -55.6% |
| 2011 | 0.50x | $326.94 Billion | $649.75 Billion | ▼ -13.1% |
| 2010 | 0.58x | $381.17 Billion | $658.53 Billion | ▲ +25.3% |
| 2009 | 0.46x | $326.27 Billion | $706.35 Billion | ▼ -16.8% |
| 2008 | 0.56x | $292.50 Billion | $526.75 Billion | ▲ +62.2% |
| 2007 | 0.34x | $209.28 Billion | $611.38 Billion | ▼ -36.4% |
| 2006 | 0.54x | $373.57 Billion | $693.87 Billion | ▼ -0.9% |
| 2005 | 0.54x | $295.54 Billion | $544.02 Billion | ▼ -3.2% |
| 2004 | 0.56x | $311.12 Billion | $554.65 Billion | ▲ +4.7% |
| 2003 | 0.54x | $263.45 Billion | $491.64 Billion | ▲ +12.7% |
| 2002 | 0.48x | $240.59 Billion | $505.88 Billion | ▲ +11.3% |
| 2001 | 0.43x | $212.66 Billion | $497.69 Billion | — |